Two satisfied customers from the UK report about the introduction of the BÜHLMANN fCAL® turbo in combination with the CALEX® Cap for their calprotectin measurements. Both laboratories applied the assay on their Cobas® platforms and integrated the turbidimetric analysis into their daily routine work.
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
For the second year, Boussias Communications and Health Daily organized the Healthcare Business Awards 2017 in Greece. The award is meant to showcase and reward innovative healthcare actions. This year the AbbVie Greece received the Gold Award in the Health Innovation category. Together with BÜHLMANN Laboratories AG and the home care provider PCC Hellas AbbVie implemented IBDoc® into
In this video, Dr James Turvill from the York Teaching Hospital introduces and details the York Faecal Calprotectin Care Pathway. He gives a short introduction on the role of calprotectin in stool samples in inflammatory bowel disease (IBD) and its use according to the NICE guidelines. Under his leadership, the local IBD Team developed a Care
Interview with Carmela Gugliotta, Laborgemeinschaft 1, Zurich Deutsch Français Italiano English INTERVIEW* MIT CARMELA GUGLIOTTA, Laborgemeinschaft 1, Zürich Frau Gugliotta, Sie haben sich vor einigen Monaten entschieden, den BÜHLMANN fCAL® turbo Test auf dem Roche Cobas® c501 in Ihrem Labor zu adaptieren. Aus welchem Grund? Von unseren Einsendern wurde der Wunsch an uns herangetragen, den
Social Links